Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-03-18

FDA Approved: NAPROXEN SODIUM HEADACHE PAIN — Original Application (Aurohealth LLC)

View source ↗

Summary

FDA approved the original ANDA for Naproxen Sodium Headache Pain, a generic naproxen product manufactured by Aurohealth LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen Sodium Headache Pain (naproxen sodium)

Snippet

ORIG AP for NAPROXEN SODIUM HEADACHE PAIN (NAPROXEN SODIUM)